What factors affect GI motility hence absorption?- How do they affect the rate of gastric empyting?
- meal volume: larger the meal, the quicker the initial emptying rate, but then depends on...- meal type: fatty acids, triglycerides and carbohydrates decrease emptying rate- state of contents: solutions empty quicker (increase rate)- chemicals: acids increase rate, alkalis increase rate at [low] and increase rate at [high]- Drugs: eg anticholinergics decrease emptying rate- body position: lying on LEFT side decreases rate- disease or vigorous exercise decrease rate
How does type of meal affect gastric emptying rate?
- fatty acids decrease rate, proportional to [conc] and hydrocarbon chain length- triglycerides decrease rate, unsaturated more so than saturated- carbohydrates/amino acids decrease rate, proportional to [conc]
IR vs gastro-resistant tablets- where are they released?
IR: immediate release, in stomach- in fasting state, drug leaves stomach quickly and rapidly via pylorusGR: Gastro-resistant/enteric coated = same thing- can't pass pylorus, so must wait for housekeeper wave- lag time: slower release into small intestine where it needs to dissolve polymer before absorption- GR gives delayed onset of action, even if same bioavailability due to lag time
Use prodrugs to modify structureEg bacampicillin = ester of ampicillin (which has poor oral bioavailability)- ampicillin = principle metabolite - physicochem properties of bacampicillin allow easier passage across intestinal barrierSO bacampicillin delivered, and metabolised to give ampicillin
liver reduces bioavailability of a drug if drug is transformed into inactive metabolite- drug moves to liver from small intestine via portal vein (w/deoxygenated blood)- a fraction of drug absorbed is converted to metabolite (active or inactive)
A fraction of a drug can be absorbed and transformed into an active metabolite by the liverEg clomipramine: principal metabolite is active.Pharmacological activity of metabolite is similar to that of the parent drug- no dose adjustment required
- drugs are transported to liver via portal vein to liver (w/deox. blood from GI tract)- some drugs travel through bile, and are secreted back into the small intestine = second passage, so can be absorbed again by small intestine to reach systematic circulation
Sometimes a drug's removal rate from a cell is more efficient than rate of entry.What are advantages/disadvantages of this?
- good protective mechanism- prevents accumulation of toxic substances- why some tumour cells are resistant to anticancer drugs: drugs are removed from cell so efficiently that [drug] conc is never high enough to be effective
= P-Glycoprotein-efflux pump protein that prevents the accumulation of certain drugs by pumping them straight out of cells- good for host defense, but responsible for poor bioavailability
PGP prevents chemotherapeutic drugs from entering tumour cells. It prevents oral delivery of many anticancer drugs due to its location in intestinal epithelial cells.How can we overcome this?

co-administer PGP inhibitors with chemotherapeutic drugsthis should prevent efflux from endothelial cells and increase oral bioavailability
- enables accurate dosing- protects drug during storage and administration- masks unpleasant tastes/odour- easy delivery- optimise delivery and release, eg IR/MR
How does Presence of Food affect bioavailability?Why is this hard to study?
Amount of drug reaching systematic circulation may be increased, decreased or unaffected by foodHard to study bc lots of inter/intra pt variability, incl dif eating habits and cultures